A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Viatris Inc stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 510,700 shares of VTRS stock, worth $5.84 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
510,700
Previous 510,700 -0.0%
Holding current value
$5.84 Million
Previous $6.1 Billion 10.97%
% of portfolio
0.96%
Previous 1.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$8.77 - $10.85 $3,990 - $4,936
-455 Reduced 0.09%
510,700 $5.53 Billion
Q3 2023

Oct 30, 2023

BUY
$9.59 - $11.35 $4.9 Million - $5.8 Million
511,155 New
511,155 $5.04 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Yelin Lapidot Holdings Management Ltd. Portfolio

Follow Yelin Lapidot Holdings Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yelin Lapidot Holdings Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yelin Lapidot Holdings Management Ltd. with notifications on news.